These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 6008774)

  • 21. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
    Kumaran MS; Kaur I; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
    Rigopoulos D; Gregoriou S; Daniel Iii CR; Belyayeva H; Larios G; Verra P; Stamou C; Kontochristopoulos G; Avgerinou G; Katsambas A
    Dermatology; 2009; 218(4):338-41. PubMed ID: 19212110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation on the long-term use of halometasone ointment in chronic eczema and psoriasis.
    Weitgasser H; Yawalkar SJ
    J Int Med Res; 1983; 11 Suppl 1():34-7. PubMed ID: 6339291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of halometasone ointment in the treatment of paediatric patients with chronic eczematous dermatoses.
    Herz G; Yawalkar SJ; Weirich EG
    J Int Med Res; 1983; 11 Suppl 1():21-5. PubMed ID: 6339288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical availability of betamethasone dipropionate and gentamicin sulfate from cream and ointment.
    Dyderski S; Grześkowiak E; Szałek E; Mrzygłód A
    Acta Pol Pharm; 2002; 59(2):99-103. PubMed ID: 12365612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of safety and efficacy of supirocin-B (mupirocin 2% + betamethasone dipropionate 0.05%) in infected dermatoses--a post marketing study.
    Savant S; Janaki VR; Mittal RR; Sengupta S; Desai A
    J Indian Med Assoc; 2000 Apr; 98(4):194-5. PubMed ID: 11016191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The experience of using fucidin and fucicort in the treatment of servicemen with pyodermia].
    Glad'ko VV; Masiukova SA; Kakhishvili NN; Tarasenko GN
    Voen Med Zh; 2007 May; 328(5):21-4. PubMed ID: 17726960
    [No Abstract]   [Full Text] [Related]  

  • 29. [A trial of the use of Triderm preparations].
    Komaristov IA
    Voen Med Zh; 2000 May; 321(5):40-1. PubMed ID: 10860451
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigation of fatty acid esters to replace isopropyl myristate in the sterility test for ophthalmic ointments.
    Cardoso VM; Solano AG; Prado MA; Nunan Ede A
    J Pharm Biomed Anal; 2006 Nov; 42(5):630-4. PubMed ID: 16831530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of a delayed action corticoid in cancerology practice].
    Toubiana CG
    Therapeutique; 1969 May; 45(5):522-5. PubMed ID: 5791833
    [No Abstract]   [Full Text] [Related]  

  • 32. [A new synthetic corticoid (its use in surgery)].
    Poilleux F; Julliard A
    Actual Hepatogastroenterol (Paris); 1965; 1(1):xx-xxiv. PubMed ID: 5875014
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study.
    Panahi Y; Moharamzad Y; Beiraghdar F; Naghizadeh MM
    Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):171-5. PubMed ID: 19143752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biologic availability of diflucortolone-21-valerate in human skin].
    Täuber U
    Arzneimittelforschung; 1983; 33(10):1503-7. PubMed ID: 6686053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative multicentre trial of halometasone ointment and fluocortolone plus fluocortolone caproate ointment in the treatment of psoriasis.
    Fabry H; Yawalkar SJ
    J Int Med Res; 1983; 11 Suppl 1():26-30. PubMed ID: 6339289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect on plasma cortisol level and urinary cortisol excretion, in healthy volunteers, after application of three different topical steroid ointments under occlusion.
    Scott M; Malmsten LA; Thelin I
    Acta Derm Venereol; 1981; 61(6):543-6. PubMed ID: 6177167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diprosalic in the therapy of psoriasis and atopic dermatitis].
    Krivosheev BN
    Voen Med Zh; 1999 Mar; 320(3):39-40. PubMed ID: 10319709
    [No Abstract]   [Full Text] [Related]  

  • 38. Circulatory effects of nitroglycerin ointment (Nitrong) with special reference to venous distensibility.
    Nyberg G; Panfilov V; Sivertsson R
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):91-5. PubMed ID: 6421758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Corticoid ointment in current use with special reference to its fatty acid ester].
    Kobayashi T
    Hifuka Kiyo; 1966 Aug; 61(3):249-56. PubMed ID: 6008774
    [No Abstract]   [Full Text] [Related]  

  • 40. Betamethasone valerate ointment (Valisone).
    Med Lett Drugs Ther; 1969 Sep; 11(18):76. PubMed ID: 5820569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.